Vaxxinity Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-56.93	-75.22	-137.18	-39.96	-14.22
Depreciation & Amortization	2.23	1.68	1.1	0.72	0.11
Share-Based Compensation	7.51	8.71	30.69	0	1.23
Other Operating Activities	-10.05	8.9	24.39	5.33	0.62
Operating Cash Flow	-57.24	-55.93	-80.99	-33.91	-12.27
Capital Expenditures	-0.8	-1.87	-1.32	-1.48	0
Change in Investments	29.65	-52.53	0	0	0
Investing Cash Flow	28.84	-54.39	-1.32	-1.48	0
Share Issuance / Repurchase	0.45	0.26	71.25	0.17	0.02
Debt Issued / Paid	-1.59	-0.43	2.33	6.74	11.12
Other Financing Activities	-	-	122.59	189.26	-
Financing Cash Flow	-1.14	-0.17	196.17	196.17	11.14
Net Cash Flow	-29.53	-110.49	113.86	113.86	-1.13
Free Cash Flow	-58.04	-57.79	-82.31	-35.39	-12.27
Free Cash Flow Margin	-	-	-124709.09%	-6353.14%	-
Free Cash Flow Per Share	-0.46	-0.46	-1.07	-0.54	-0.23

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).